Cancer Stem Cells
Cancer Stem Cells - Related Videos
07:29
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
0 Views •
Cited by 27 •
2015
Pancreatic cancer stem cells (CSCs) can be expanded in vitro using the anchorage-independent sphere culture technique, which represents a powerful tool to study CSC biology and can serve as the first step to develop novel CSC-targeting therapies. Here the methodology for expanding, analyzing and targeting of pancreatic CSCs is provided.
07:16
Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
0 Views •
Cited by 6 •
2014
The isolation of cancer stem cells (CSCs) directly from human tissues is requisite for their biological characterization. This manuscript describes a methodology for the isolation of prostate CSCs from human tissues, while also providing tips on troubleshooting difficult steps.
11:44
Isolation of Stem Cells from Human Pancreatic Cancer Xenografts
0 Views •
Cited by 40 •
2010
Cancer stem cells (CSCs) have been identified in a number of malignancies. In this protocol we describe a flow cytometric method utilizing aldehyde dehydrogenase activity and CD44 and CD24 expression to isolate CSCs from human pancreatic adenocarcinoma xenografts. These viable cells can then be used in functional and analytical studies.
09:36
Evaluation of Cancer Stem Cell Migration Using Compartmentalizing Microfluidic Devices and Live Cell Imaging
0 Views •
Cited by 26 •
2011
A compartmentalizing microfluidic device for investigating cancer stem cell migration is described. This novel platform creates a viable cellular microenvironment and enables microscopic visualization of live cell locomotion. Highly motile cancer cells are isolated to study molecular mechanisms of aggressive infiltration, potentially leading to more effective future therapies.
03:14
PDAC Stem Cell Isolation: A Method to Isolate Cancer Stem Cells from Pancreatic Tumors
0 Views •
2023
This article describes the technique for isolating pancreatic cancer stem cells (CSCs) from human pancreatic ductal adenocarcinoma (PDAC) tissue. These CSCs are used to study the functional effects of drug treatment on the in vitro self-renewal capacity of CSCs for developing more efficient cancer treatments.
FAQs
Division patterns help determine how a tumor-maintaining population is preserved while differentiated cancer cells are produced. Asymmetric division can maintain the stem-cell pool while generating more differentiated progeny, whereas symmetric division can contribute to maintaining or expanding cells with similar stem-like properties. The balance between these outcomes influences tumor development and cellular composition.
Quiescence places cancer stem cells in a relatively inactive state, which may reduce their sensitivity to treatments that affect actively functioning or dividing tumor cells. Protective signaling pathways can provide an additional survival advantage. Together, these features may allow some cells to persist during treatment and later contribute to tumor recurrence.
Protective signaling pathways can help cancer stem cells withstand conditions that damage or eliminate other tumor cells. Their activity is important because survival of this subpopulation may preserve tumor-maintaining capacity even when the overall tumor burden is reduced. Studying these pathways helps explain treatment resistance and may reveal targets for complementary therapeutic strategies.
Cancer stem cells provide a framework for understanding why tumors can contain diverse cell populations with different properties. Their capacity to generate more differentiated cancer cells may contribute to heterogeneity, while persistence and tumor-maintaining activity are relevant to metastasis and recurrence. Investigating these relationships connects cellular behavior with major stages of tumor development.
Identification and characterization allow researchers to investigate which tumor cells have stem-like capacities and how those cells behave within cancer biology. This work can clarify mechanisms involved in tumor initiation, heterogeneity, metastasis, and recurrence. The resulting information supports comparisons between tumor-maintaining populations and other cancer cells without treating the tumor as a uniform population.
Cancer stem cell research supports strategies that target tumor-maintaining populations alongside conventional treatments. This combined approach is intended to address cells that may remain quiescent or activate protective pathways during therapy. By including these populations in treatment design, researchers aim to improve disease control and reduce the likelihood that surviving cells contribute to relapse.